Metabolomic Profiling of Adipose Tissue in Type 2 Diabetes: Associations with Obesity and Insulin Resistance

• Published in: Metabolites Vol. 14; no. 8; p. 411
• Main Authors: Mathioudaki, Argyri, Fanni, Giovanni, Eriksson, Jan W, Pereira, Maria J
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26.07.2024; MDPI
• Subjects: Adipocytes; Adipose tissue; Adipose tissues; Amino acids; Body fat; Body mass index; Branched chain amino acids; Carbohydrates; Correlation analysis; Dextrose; Diabetes; Diabetes mellitus (non-insulin dependent); Energy metabolism; Fatty acids; Glucose; Glucose metabolism; glucose uptake; Health aspects; Hypoglycemic agents; Insulin resistance; insulin sensitivity; Intermediates; Metabolism; Metabolites; Metabolomics; Obesity; Peptides; Physiological aspects; Principal components analysis; Public health; Therapeutic targets; Tricarboxylic acid cycle; Type 2 diabetes; Unsaturated fatty acids; United States > US; adipose tissue; insulin sensitivity; type 2 diabetes; glucose uptake; metabolomics
• ISSN: 2218-1989; 2218-1989
• DOI: 10.3390/metabo14080411

The global prevalence of Type 2 Diabetes (T2D) poses significant public health challenges due to its associated severe complications. Insulin resistance is central to T2D pathophysiology, particularly affecting adipose tissue function. This cross-sectional observational study investigates metabolic alterations in subcutaneous adipose tissue (SAT) associated with T2D to identify potential therapeutic targets. We conducted a comprehensive metabolomic analysis of SAT from 40 participants (20 T2D, 20 ND-T2D), matched for sex, age, and BMI (Body Mass Index). Metabolite quantification was performed using GC/MS and LC/MS/MS platforms. Correlation analyses were conducted to explore associations between metabolites and clinical parameters. We identified 378 metabolites, including significant elevations in TCA cycle (tricarboxylic acid cycle) intermediates, branched-chain amino acids (BCAAs), and carbohydrates, and a significant reduction in the nucleotide-related metabolites in T2D subjects compared to those without T2D. Obesity exacerbated these alterations, particularly in amino acid metabolism. Adipocyte size negatively correlated with BCAAs, while adipocyte glucose uptake positively correlated with unsaturated fatty acids and glycerophospholipids. Our findings reveal distinct metabolic dysregulation in adipose tissue in T2D, particularly in energy metabolism, suggesting potential therapeutic targets for improving insulin sensitivity and metabolic health. Future studies should validate these findings in larger cohorts and explore underlying mechanisms to develop targeted interventions.